Brendan P. Eckelman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
La Jolla, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kelly D. Deck, Chief Financial Officer of Inhibrx Biosciences, Inc., as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Brendan P. Eckelman

Form 4 holding Chief Scientific Officer

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
433,888
Estimated value
$5,610,172
Report date
29 May 2024
Price
$12.93
Ownership
By the Eckelman Living Trust Dated February 5, 2014
Form 4 holding Chief Scientific Officer

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
40,000
Estimated value
$517,200
Report date
29 May 2024
Price
$12.93
Ownership
By trust
Form 4 holding Chief Scientific Officer

Inhibrx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
30 May 2024
Price
$30.00
Ownership
By the Eckelman Living Trust dated February 5, 2014
Form 4 holding Chief Scientific Officer

Inhibrx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
30 May 2024
Price
$30.00
Ownership
By trust
Form 4 holding Chief Scientific Officer

Inhibrx, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
$0
Report date
30 May 2024
Price
$34.12
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Scientific Officer

Inhibrx Biosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
175,000
Estimated value
Report date
30 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Brendan P. Eckelman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .